Clinical Trial Update: A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating LCAR-AIO for relapsed/refractory systemic lupus erythematosus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• LCAR-AIO

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Systemic Lupus Erythematosus (SLE) | EARLY_Phase 1 | Status: RECRUITING